GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
BALLELL PAGES, LLUIS,BARROS AGUIRRE, DAVID,BATES, ROBERT H,CASTRO PICHEL, JULIA,ESQUIVIAS PROVENCIO, JORGE,PETHE, KEVIN
申请号：
CA3018611
公开号：
CA3018611A1
申请日:
2017.03.20
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to the use in therapy of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione or a pharmaceutically acceptable salt thereof, including use as an anti-mycobacterial, for example in the treatment of tuberculosis； compositions containing 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione； combinations comprising 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione or a pharmaceutically acceptable salt thereof and salts of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione.
